维普中文期刊产品整合服务
18篇 您的检索式:作者名="NAGA PRASAD SV"
    题名 作者 年代 出处 被引量
1Level of beta- adrenergic receptor kinase 1 inhibition determines degree of cardiac dysfunction after chronic pressure overload-inducad heart failure 显示文摘Tachibana H Naga Prasad SV Lefkowitz RJ 2005Circulation2005,111,5:1
2Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress 显示文摘Esposito G Rapacciuolo A Naga Prasad SV 2002Circulation2002,105,1:1
3Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress显示文摘Esposito G Rapacciuolo A Naga Prasad Sv 2002Circulation2002,105,:1
4Genetic aherationstha inhibit in vivo pressure - overload hypertrophy prevent cardiacdysfunction despite increased wall stress 显示文摘ESPOSITO G RAPACCIUOLO A NAGA PRASAD SV 2002Circulation2002,105,:1
5Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress显示文摘Esposito G Rapacciuolo A Naga Prasad SV 2002Circulation2002,105,:1
6Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks显示文摘Naga Prasad SV Duan ZH Gupta MK 2009J Biol Chem2009,284,27:1
7Gbetagamma-dependent phosphoinositide 3-kinase activation inhearts with in vivo pressure overload hypertrophy显示文摘Naga Prasad SV Esposito G Mao L 2010J Biol Chem2010,275,:1
8Level of beta-adrenergic receptor kinase 1 inhibition determines degree of cardiac dysfunction after chronic pressure overloadinduced heart failure显示文摘TACHIBANA H NAGA PRASAD SV LEFKOWITZ RJ 2005Circulation2005,111,5:1
9Differential effects of Aktl signaling on short-versus long-term consequences of myocardial infarction and reperfusion injury 显示文摘Ma L Kerr BA Naga Prasad SV 2014Lab In- vest2014,94,:1
10Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress显示文摘 Rapacciuolo A Naga Prasad SV 2002Circulation2002,105,:1
11Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks显示文摘Naga Prasad SV Duan ZH Gupta MK 2009J Biol Chem2009,284,27:1
12Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks显示文摘Naga Prasad SV Duan ZH Gupta MK 0,,:1
13Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks显示文摘Naga Prasad SV Duan ZH Gupta MK 2009J Biol Chem2009,284,27:1
14Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress显示文摘Esposito G Rapacciuolo A Naga Prasad SV Takaoka H Thomas SA Koch WJ 2002Circulation2002,105,1:1
15Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress显示文摘Esposito G Rapacciuolo A Naga Prasad SV 2002Circulation2002,105,8:1
16Unique micro RNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks显示文摘Naga Prasad SV Duan ZH Gupta MK 2009J Biol Chem2009,284,27:1
17Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress显示文摘Esposito G Rapacciuolo A Naga Prasad SV 2002Circulation2002,105,15:1
18Phosphoinositide3-kinase regulates beta2-adrener-gic receptor endocytosis by AP-2recruitment to the receptor/beta-arrestin complex显示文摘Naga Prasad SV Laporte SA Chamberlain D Caron MG Barak L Rockman HA 2002J Cell Biol2002,158,3:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费